Jerome L

MAPS Public Benefit Corporation, Santa Cruz, CA, USA.

9 papers · ORCID

Retraction Note: Discontinuation of medications classified as reuptake inhibitors affects treatment response of MDMA-assisted psychotherapy.

Feduccia AA, Jerome L, Mithoefer MC +1

Retraction Note: Long-term follow-up outcomes of MDMA-assisted psychotherapy for treatment of PTSD: a longitudinal pooled analysis of six phase 2 trials.

Jerome L, Feduccia AA, Wang JB +5

Retraction Note: MDMA-assisted psychotherapy for treatment of PTSD: study design and rationale for phase 3 trials based on pooled analysis of six phase 2 randomized controlled trials.

Mithoefer MC, Feduccia AA, Jerome L +7

Breakthrough for Trauma Treatment: Safety and Efficacy of MDMA-Assisted Psychotherapy Compared to Paroxetine and Sertraline.

Feduccia AA, Jerome L, Yazar-Klosinski B +3

Concomitant medications associated with ischemic, hypertensive, and arrhythmic events in MDMA users in FDA adverse event reporting system.

Makunts T, Dahill D, Jerome L +2

MDMA-assisted psychotherapy for treatment of anxiety and other psychological distress related to life-threatening illnesses: a randomized pilot study.

Wolfson PE, Andries J, Feduccia AA +10

ArticlePsilocybin

Integrating psychotherapy and psychopharmacology: psychedelic-assisted psychotherapy and other combined treatments.

Greenway KT, Garel N, Jerome L +1

ArticlePsilocybin

The Past and Future of Psychedelic Science: An Introduction to This Issue.

Doblin RE, Christiansen M, Jerome L +1

History and future of the Multidisciplinary Association for Psychedelic Studies (MAPS).

Emerson A, Ponté L, Jerome L +1